Life sciences spotlight — September 2013

DLA Piper has published the second issue of its Life Sciences Spotlight publication for 2013.

Contents

  • A new wave of regulatory enforcement actions in China
  • Australia’s innovation patent
  • Best practice disclosure for life sciences companies
  • The new workplace bullying laws and performance management
  • Can reverse payments in patent settlements constitute criminal cartel conduct?
  • Unravelling the helix

If you are registered and logged in to the site, click on the link below to read the DLA Piper briefing. If not, please register or sign in with your details below

Briefings from DLA Piper

View more briefings from DLA Piper

Analysis from The Lawyer

View more analysis from The Lawyer

Overview

3 Noble Street
London
EC2V 7EE
UK
http://www.dlapiper.com

Turnover (£m): 1,539.00
No. of lawyers: 4,374(UK 200)
Jurisdiction: Global
No. of offices: Over 75
No. of qualified lawyers: 625 (International 50)

Jobs